Phaseline

Companies › Grit Biotechnology

Grit Biotechnology: clinical trials, targets and expected readouts

3 active drug programs in 7 registered trials: 6 Phase 1, 1 Phase 2; Oncology, Neurology, Other; next expected readout Dec 2026.

Open in Phaseline: competitors, likelihood bands and readouts Company report

Programs

DrugTargetHighest phaseConditionsNext expected readout
TIL injection
Autologous tumor infiltrating lymphocyte injection
–Phase 2Adult; Solid Tumors, Adult; Advanced Solid TumorsDec 2026
IB-T101 injection–Phase 1Advanced Clear Renal Cell CarcinomaDec 2027
GT719 Injection
anti-CD19 CAR-T cell therapy
CD19Phase 1Neurological Autoimmune Diseases; Hematological Malignancy (Leukemia- Lymphoma)Jan 2028

Trials

Registry idDrugPhaseConditionsAreaExpected readout
NCT05430373TIL injectionPhase 1Solid Tumors, AdultOncologyDec 2026
NCT06241781TIL injectionPhase 2AdultOtherJan 2027
NCT06819293IB-T101 injectionPhase 1Advanced Clear Renal Cell CarcinomaOncologyDec 2027
NCT06144671TIL injectionPhase 1Advanced Solid TumorsOncologyDec 2027
NCT06088472TIL injectionPhase 1Solid Tumors, AdultOncologyDec 2027
NCT07021209GT719 InjectionPhase 1Neurological Autoimmune DiseasesNeurologyJan 2028
NCT06948981GT719 InjectionPhase 1Hematological Malignancy (Leukemia- Lymphoma)OncologyApr 2028

Targets

CD19 (1)

Companies with the same targets

Gilead Sciences Bristol-Myers Squibb Chongqing Precision Biotech Allogene Therapeutics Miltenyi Biomedicine Amgen AstraZeneca Beijing Yongtai Ruike Biotechnology Company Shanghai Ming Ju Biotechnology iCell Gene Therapeutics

Companies built like this

Juventas Cell Therapy Beijing Yongtai Ruike Biotechnology Company Miltenyi Biomedicine Takara Bio Shanghai Ming Ju Biotechnology

Pipelines of the same shape: areas, drug types, target families, stage and cash runway.

Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.